Full Project List

Since our inception as an outcome committee in 2015, we have consistently and considerably expanded our ability to produce rigorous outcomes research. In 2018, we established a more formal program and leadership, including full time outcomes research staff. The result of these allocated resources has been a productive output across multiple specialty disease states. Below are highlighted outcomes from studies completed in recent years.

Sponsored Projects:

Zuckerman A, Peter M, Cooper K, Jones A, Choi L, DeClercq J, Tanner SB, James C, Choi J. Impact of pharmacist collaborative practice in rheumatoid arthritis. Source: Sanofi Inc. December, 2018.

Horst S, Shah N, Wolever R, Schwartz D, Beaulieu D, Dalal R, Zuckerman A. Health coaching to improve medication in IBD. Source: AbbVie Inc. December, 2018.

Koren D, Martin M, Zuckerman A, Teply R, Nabulsi N, Lee T. Expanding hepatitis c virus care and cure: national experience using a clinical pharmacist-driven model. Source: Gilead Science, Inc. December, 2017.

Peer-Reviewed Manuscripts Published:

Zuckerman A, Anguiano RH, Jolly JA, DeClercq J, Wascher M, Choi L, Knox S, Mitchell DF. Navigating the wild west of medication adherence reporting in specialty pharmacy. J Manag Care Spec Pharm, 2019 Oct; 25(10):1073-1077.

Shah NB, Jolly JA, Horst SN, Peter M, Limper H, Zuckerman AD. Development of a quality measures tool for the use of self-injectable biologic therapy in inflammatory bowel disease: an integrated specialty pharmacy initiative. Am J Health Syst Pharm, 2019 Sep; 76(17): 1296-1304

Merchant SL , Culos K, Wyatt H. Ivosidenib: idh1 inhibitor for the treatment of acute myeloid leukemia. J Adv Pract Oncol, 2019 Jul; 10(5):494-500.

Koren D , Zuckerman A, Teply R, Nabulsi N, Lee T, Martin M. Expanding hepatitis c virus care and cure: national experience using a clinical pharmacist-driven model. Open Forum Infect Dis, 2019 Jul; 6(17):ofz316. doi:10.1093/ofid/ofz316.

Shah NB, Mitchell RE, Proctor ST, Choi L, DeClercq J, Jolly JA, Hemnes AR, Zuckerman AD. High rates of medication adherence in patients with pulmonary arterial hypertension: an integrated specialty pharmacy approach. PloS One, 2019 Jun; 14(6):e0217798. doi: 10.1371/journal.pone.0217798.

Cornell RF, Goldhaber SZ, Engelhardt BG, Moslehi J, Jagasia M, Patton D, Patton D, Harrell S, Hall R, Wyatt H. Apixaban for primary prevention of venous thromboembolism in patients with multiple myeloma receiving immunomodulatory therapy. Front Oncol, 2019 Feb; 9(45):. doi: 10.3389/fonc.2019.00045.

Banks AM, Peter ME, Holder GM, Jolly JA, Markley BM, Zuckerman SL, Choi L, Nwosu S, Zuckerman AD. Adherence to disease-modifying therapies at a multiple sclerosis clinic: the role of the specialty pharmacist. J Pharm Pract, 2019 Jan; :897190018824821. doi: 10.1177/0897190018824821.

Reynolds VW, Chinn ME, Jolly JA, Kelley TN, Peter ME, Choi L, Nwosu S, Leon BC, Zuckerman AD. Integrated specialty pharmacy yields high pcsk9 inhibitor access and initiation rates. J Clin Lipidol, 2019 Jan; 13(2):254-264. doi: 10.1016/j.jacl.2019.01.003. Epub 2019 Jan 14.

Zuckerman A, Carver A, Chastain CA. Building a hepatitis c clinical program: strategies to optimize outcomes. Curr Treat Options Infect Dis, 2018 Oct; 10(4):431-446. doi: 10.1007/s40506-018-0177-5. Epub 2018 Oct 18.

Zuckerman A, Douglas A, Nwosu S, Choi L, Chastain C. Increasing success and evolving barriers in the hepatitis c cascade of care during the direct acting antiviral era. PloS One, 2018 Jun; 13(6):e0199174. doi: 10.1371/journal.pone.0199174.

Schlendorf KH, Zalawadiya S, Shah AS, Wigger M, Chung CY, Smith S, Sacks SB. Early outcomes using hepatitis c–positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies. J Heart Lung Transplant, 2018 Jun; 37(6):763-769. doi: 10.1016/j.healun.2018.01.1293. Epub 2018 Jan 31

Zuckerman A, Chastain CA, Naggie S. Retreatment options following HCV direct-acting antiviral failure. Curr Treat Options Infect Dis, 2017 Dec; 9(4):389-402. doi: 10.1007/s40506-017-0136-6. Epub 2017 Nov 4

Bagwell A, Kelley T, Carver A, Lee JB, Newman B. Advancing patient care through specialty pharmacy services in an academic health system. J Manag Care Spec Pharm, 2017 Aug; 23(8):815-820.

Bagwell A, Chastain CA. Hepatitis c treatment in HIV coinfection: approaches, challenges, and future opportunities. Curr Treat Options Infect Dis, 2016 Oct; 8(4):379-399.

Conference Podium presentations:

Chelewski R, Johnson K, Zuckerman A, DeClercq J, Choi L, Peter M, Langone A. Development of a pharmacy collaborative practice agreement to improve efficiency and management of prescribing in a renal transplant clinic. Podium presentation presented to the American Transplant Congress Annual Meeting, Boston, MA. June, 2019.

Boyle K, Edmonds C, Schlendorf K, Gray J, Lindenfeld J, Pollack A, Fowler R. Appropriate management of drug interactions results in safe use of hepatitis c therapies in heart transplant recipients. Podium presentation presented to The International Society for Heart & Lung Transplantation Annual Meeting, Orlando, FL. April, 2019.

Goettel A. Efficacy and safety of abatacept, adalimumab, and etanercept in pediatric patients with juvenile idiopathic arthritis. Podium presentation presented to the Pediatric Pharmacy Advocacy Group Annual Meeting, Oklahoma City, OK. April, 2019.

O’Dell HW, Darragh CR, Smith SS, Schlendorf K, Perri RE, Awad J, Shah AS, Edmonds C, Carver A, Chung CY. Multispecialty collaboration benefits efforts at expanding donor pools: transplanting HCV positive grafts into HCV negative heart transplant recipients. Podium presentation presented to the American Association of the Study of Liver Diseases (AASLD) The Liver Meeting, San Francisco, CA. November, 2018.

Haydek J, Shah N, Slaughter JC, Ashton J, Zuckerman A, Wong R, Raffe F, Garrett A, Duley C, Annis K, Wagnon J, Gaines L, Dalal R, Scoville E, Beaulieu D, Schwartz D, Horst S. Risk factors for non-adherence to biologic therapy in adult patients with inflammatory bowel disease (IBD): a retrospective analysis. Podium presentation presented to the American College of Gastroenterology Annual Scientific Meeting, Philadelphia, PA. October, 2018.

Haydek J, Shah N, Slaughter JC, Ashton J, Zuckerman A, Wong R, Raffe F, Garrett A, Duley C, Annis K, Wagnon J, Gaines L, Dalal R, Scoville E, Beaulieu D, Schwartz D, Horst S. Risk factors for non-adherence to biologic therapy in adult patients with inflammatory bowel disease (IBD): a retrospective analysis. Podium presentation presented to the American College of Gastroenterology Annual Scientific Meeting, Philadelphia, PA. October, 2018.

Chastain C, Johnson J, Miller K, Moore K, Lako A, Zuckerman A, Han J, Self W. Universal hepatitis c screening in a Tennessee tertiary care emergency department. Podium presentation presented to ID Week, San Francisco, CA. October, 2018.

Conference Poster presentations:

Zuckerman A, James C, Choi J, Peter M, Nadler MA, Nola KM, Jones A, Cooper K, DeClercq J, Choi L, Tanner SB. Switching and cycling among patients with rheumatoid arthritis at an integrated health system specialty pharmacy. Poster presented to the Academy of Managed Care Pharmacy Nexus Annual Meeting, National Harbor, MD. October, 2019.

Livezey S, McCormick R, Shah N, Choi L, DeClercq J, Zuckerman A. Impact of specialty pharmacist integration on time to medication access for pimavanserin. Encore poster presented to the Academy of Managed Care Pharmacy Nexus Annual Meeting, National Harbor, MD. October, 2019.

Tolle J, Slack S, Miller A, Eastman S, Hinton K, Jones S, Glenn S, Patel B. Implementing a medication reconciliation protocol for adult cystic fibrosis patients in an integrated outpatient clinic. Poster presented to the North American Cystic Fibrosis Conference, Nashville, TN. October, 2019.

Moore E, Kelly S, Alexander L, Luther P, Cooper R, Rebeiro P, Zuckerman A, Hargreaves M, Bourgi K, Schlundt D, Bonnet K, Pettit A. Healthcare provider attitudes and knowledge around pre-exposure prophylaxis (PrEP) for the prevention of HIV-infection in Tennessee. Poster presented at ID Week 2019. Washington, DC. October, 2019.

Livezey S, McCormick R, Shah N, Choi L, DeClercq J, Zuckerman A. Impact of specialty pharmacist integration on time to medication access for pimavanserin. Encore poster to be presented to the National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo, Washington, DC. September, 2019.

Nix R, Looney B, Lamb C, Peter M, Zuckerman A. A targeted approach to reducing rates of discontinuation and dose reduction in patients receiving sorafenib or regorafenib. Encore poster presented to the National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo, Washington, DC. September, 2019.

Chelewski R, Johnson K, Zuckerman A, DeClercq J, Choi L, Peter M, Langone A. Development of a collaborative pharmacy practice agreement to improve efficiency and management of prescribing in a renal transplant clinic. Encore poster presented to the National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo, Washington, DC. September, 2019.

Wyatt H, Zuckerman A, Peter M, Starks S, Maulis M, Declercq J, Choi L, Jagasia M. Predicting time to medication access for hematologic malignancies: the impact of an integrated specialty pharmacy and limited distribution drug networks. Encore poster presented to the National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo, Washington, DC. September, 2019.

Nabulsi NA, Martin MT, Sharp LK, Koren DE, Teply R, Zuckerman A, Lee TA. Prediction model of treatment failure among chronic HCV. Poster presented to the International Society for Pharmacoeconomics and Outcomes (ISPOR) Annual Meeting, New Orleans, LA. May, 2019.

Crothers G, Shah N, Kim M, Zuckerman A. Development of a quality measures tool for the utilization of tyrosine kinase inhibitors in non-small cell lung cancer: an integrated specialty pharmacy initiative. Poster presented to the Pharmacy Quality Alliance Annual Meeting, Baltimore, MD. May, 2019.

Ward-Isbell A, Peter M. Converting prescriptions to 90-day supply increases specialty pharmacy technician efficiency. Poster presented to the Pharmacy Quality Alliance Annual Meeting, Baltimore, MD. May, 2019.

Haydek J, Shah N, Zuckerman A, Wong R, Garret A, Duley C, Annis K, Wagnon J, Dalal R, Scovile E, Beaulieu D, Schwartz D, Slaughter C, Horst S. Non-adherence to self-injectable biologic medication in patients with moderate to severe inflammatory bowel disease is associated with increased healthcare resource utilization. Poster presented to the Digestive Disease Week Annual Meeting, San Diego, CA. May, 2019.

Johnson K, Haffler Z, Miller L. Pharmacist managed lithium in an inpatient academic medical center. Poster presented to the College of Psychiatric and Neurologic Pharmacists Annual Meeting, Salt Lake City, UT. April, 2019.

Livezey S, McCormick R, Shah N, Choi L, DeClercq J, Zuckerman A. Impact of specialty pharmacist integration on time to medication access for pimavanserin. Poster presented to the College of Psychiatric and Neurologic Pharmacists Annual Meeting, Salt Lake City, UT. April, 2019.

Cherry E, Jolly J, Zuckerman A, Peter M. Adherence to specialty medications: assessing rates and correlates of nonadherence at an integrated specialty pharmacy. Poster presented to the Academy of Managed Care and Specialty Pharmacy Annual Meeting, San Diego, CA. March, 2019.

Nix R, Looney B, Lamb C, Peter M, Zuckerman A. A targeted approach to reducing rates of discontinuation and dose reduction in patients receiving sorafenib or regoranfenib. Poster presented to the Academy of Managed Care and Specialty Pharmacy Annual Meeting, San Diego, CA. March, 2019. *Awarded Gold Ribbon Abstract Award

Chelewski R, Johnson K, Zuckerman A, Peter M, DeClercq J, Choi L, Langone A. Development of a pharmacy collaborative practice agreement to improve efficiency and management of prescribing in a renal transplant clinic. Poster presented to the Academy of Managed Care and Specialty Pharmacy Annual Meeting, San Diego, CA. March, 2019. *Awarded Gold Ribbon Abstract Award

Peter M, Chakrabarti A, Gipson H, Gregory WT, DeClercq J, Choi L, Gibbs K, Tanner SB. Lapses and discontinuations in denosumab therapy: associations with fracture incidence. Poster presented to the International Society for Clinical Densitometry Annual Meeting, Kuala Lumpur, Malaysia. March, 2019.

Berger N, Peter M, DeClercq J, Choi L, Zuckerman A. Adherence to disease-modifying anti-rheumatic drugs in patients in an integrated clinic and specialty pharmacy. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Anaheim, CA. December, 2018.

Zuckerman A, Peter M, Johnson J, Miller K, Chastain C. Referral source matters: the hepatitis c cascade of care for traditional versus emergency department referrals. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Anaheim, CA. December, 2018.

Cornell RF, Goldhaber S, Engelhardt BG, Moslehi J, Jagasia M, Patton D, Harrell S, Hall R, Wyatt H, Piazza G. Prospective study of apixaban for primary prevention of venous thromboembolism in patients with multiple myeloma receiving immunomodulatory therapy, a 3-month interim analysis. Poster presented to the Annual Meeting & Exposition of the American Society of Hematology, San Diego, CA. December, 2018.

Koren D, Zuckerman A, Teply R, Nabulsi N, Lee T, Martin MT. Expanding hepatitis c virus care and cure: national experience using a clinical pharmacist-driven model. Poster presented to the American Association of the Study of Liver Diseases (AASLD) The Liver Meeting, San Francisco, CA. November, 2018.

Wyatt H, Zuckerman A, Peter M, Starks S, Maulis M, Declercq J, Choi L, Jagasia M. Predicting time to medication access for hematologic malignancies: the impact of an integrated specialty pharmacy and limited distribution drug networks. Poster presented to the Academy of Managed Care Pharmacy Nexus Annual Meeting, Orlando, FL. October, 2018.

Paolella D, Zuckerman A, Cherry E, Jolly J. Closing the gap: identifying rates and reasons for nonadherence in a specialty population. Poster presented to the Academy of Managed Care Pharmacy Nexus Annual Meeting, Orlando, FL. October, 2018. *Awarded Silver Ribbon Abstract Award

Reynolds V, Peter M, Jolly J, Chinn M, Nwosu S, Choi L, Zuckerman A. Impact of an integrated clinical and specialty pharmacy service model on access to PCSK9 inhibitor therapy. Encore poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2018.

Cherry E, Jolly JA, Zuckerman A. Using rates of non-adherence to identify opportunities for intervention in outpatient specialty clinics. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2018.

Lines TH, Carver AB, Zuckerman A, Chastain CA. Persistent viremia on DAA therapy: real-world experience, interventions, and outcomes. Poster presented to the American College of Clinical Pharmacy Updates in Therapeutics, Jacksonville, FL. February, 2018.

Douglas A, Chastain C, Zuckerman A. Adjustments to antiretroviral therapy regimens in co-infected human immunodeficiency virus and hepatitis c virus patients. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Orlando, FL. December, 2017.

Singleton E, Boils B, Litten K, Burkes S, Zuckerman A. Factors that impact treatment completion of teriparatide. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Orlando, FL. December, 2017.

Chinn M, Reynolds V, Jolly J, Zuckerman A, Kelley T. Impact of an integrated clinical and specialty pharmacy service model on access to PCSK9 inhibitor therapy. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Orlando, FL. December, 2017.

Zuckerman A, Douglas A, Farris K, Chastain C. Merit project: optimizing the hepatitis c cascade of care in the direct-acting antiviral era. Poster presented to the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ. October, 2017.

Bagwell A, Douglas A, Farris K, Chastain C. Evaluation of the hepatitis c cascade of care in a multidisciplinary infectious diseases clinic. Poster presented to ID Week, San Diego, CA. October, 2017.

Bagwell A, Chastain C. Improvements following clinical pharmacist integration in the management of hepatitis c. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2017.

Jolly J, Markley B, Holder G, Banks A, Zuckerman S, Zuckerman A. Improving adherence to multiple sclerosis disease modifying therapies through an integrated specialty pharmacy model. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2017.

Mitchell R, Shah N, Terry S, Slack S, Zuckerman A, Jolly J. Improving medication adherence in pulmonary arterial hypertension: an integrated specialty pharmacy approach. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2017.

Carver A, Porayko M. Retreatment of genotype 1 hepatitis c virus with sofosbuvir, simeprevir, and ribavirin following treatment failure with an ns5a-containing direct-acting antiviral regimen. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2017.

Singleton E, Boils B, Litten K, Burkes S, Zuckerman A. Assessing the impact of high touch specialty pharmacy services in patients receiving teriparatide. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2017.

Bagwell A, Farris K, Chastain C. MeRit project: optimizing the hepatitis c cascade of care in the direct-acting antiviral era. Poster presented to the American College of Clinical Pharmacy Annual Meeting, Hollywood, FL. October, 2016.

Bagwell A, Chastain C. An interdisciplinary team approach to hepatitis c evaluation and treatment: assessing the impact of clinical pharmacist involvement on HCV clinical practice and treatment. Poster presented to the American College of Clinical Pharmacy Annual Meeting, Hollywood, FL. October, 2016.

Nelsen C, Carver A. Real world assessment of all-oral, sofosbuvir-based, hepatitis c therapy at an academic medical center with integrated specialty pharmacy services. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2016.

Beavers J, Nelsen C, Carver A, Bagwell A. Real world assessment of interferon free oral sofosbuvir based therapy in hepatitis c patients. Poster presented to the Southeastern Resident Conference (SERC), Athens, GA. May, 2016.